EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Population pharmacokinetics of caspofungin in critically ill Chinese children: a prospective observational study

Nuo Xu iD, Yufei Shi iD, Gehang Ju, Xin Liu, Gangfeng Yan, Yi Zheng, Shuyu Hou, Xiaoqiang Xiang, Guoping Lu, Dongsheng Ouyang, Xiao Zhu iD, Yixue Wang iD

Antimicrobial Agents and Chemotherapy · 2026

DOI: 10.1128/aac.01277-25 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2026. Verfasst von Nuo Xu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmacy, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Caspofungin, Antifungal Agents. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Municipal Health Commission Clinical Research Youth Project, National Natural Science Foundation of China, Hunan Key Laboratory for Bioanalysis of Complex Matrix Samples.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While caspofungin is increasingly used to treat invasive fungal infections in pediatric intensive care unit (PICU) patients, its pharmacokinetic profile in this population remains poorly understood, and current dosing regimens are not firmly supported by scientific evidence. This study aimed to characterize the population pharmacokinetics of caspofungin in critically ill children and to identify dosing strategies for optimal exposure. The prospective clinical study was conducted among pediatrics in PICU. Population pharmacokinetic analysis and Monte Carlo simulations were performed. A total of 138 plasma samples collected from 29 pediatric patients (0.33–16 years) were included in the final analysis. The two-compartment model with allometric scaling on body surface area (BSA, exponential 1 for volume of distribution and 0.66 for clearance) accurately described time courses of caspofungin. Extracorporeal membrane oxygenation (ECMO) significantly increased the central volume of distribution (effect coefficient 18.2). There was no significant difference in area under the concentration curve (AUC) between patients with and without ECMO support. Simulations demonstrated that tAUC ss,24h /MIC-based PTA results showed no significant differences between ECMO and non-ECMO groups and supported the current dosing regimen. A fixed maintenance dose (MD) is appropriate for patients with BSA ≥ 1.4 m², while the standard BSA-based MD remains preferable for those with BSA

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CaspofunginAntifungal AgentsHumansCritical IllnessChildFemaleMaleProspective StudiesChild, PreschoolInfantAdolescentExtracorporeal Membrane OxygenationMonte Carlo MethodMicrobial Sensitivity TestsIntensive Care Units, PediatricArea Under CurveChinaEast Asian People

Stichwörter der Autor:innen

ECMOcaspofunginintensive care unitspediatricspopulation pharmacokinetics

Substanzen

CaspofunginAntifungal Agents

Autor:innen und Institutionen

  • Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmacy, Fudan University, Shanghai, China.
  • School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
  • Pediatric Intensive Care Unit, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
  • DMPK department, Suzhou Frontage New Drug Development Co.,Ltd, Suzhou, Jiangsu, China.
  • State Key Laboratory of Advanced Drug Formulations for Overcoming Delivery Barriers, Fudan University, Shanghai, China.

ORCID-Profile: Nuo Xu, Yufei Shi, Xiao Zhu, Yixue Wang

Förderung

  • Shanghai Municipal Health Commission Clinical Research Youth Project
  • National Natural Science Foundation of China
  • Hunan Key Laboratory for Bioanalysis of Complex Matrix Samples
  • Children's Hospital of Fudan University, China

Zitieren

APA

Xu, N., Shi, Y., Ju, G., Liu, X., Yan, G., Zheng, Y., Hou, S., Xiang, X., Lu, G., Ouyang, D., Zhu, X., & Wang, Y. (2026). Population pharmacokinetics of caspofungin in critically ill Chinese children: a prospective observational study. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01277-25

Vancouver

Xu N, Shi Y, Ju G, Liu X, Yan G, Zheng Y, et al. Population pharmacokinetics of caspofungin in critically ill Chinese children: a prospective observational study. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.01277-25

BibTeX
@article{Xu2026,
  author = {Xu, Nuo and Shi, Yufei and Ju, Gehang and Liu, Xin and Yan, Gangfeng and Zheng, Yi and Hou, Shuyu and Xiang, Xiaoqiang and Lu, Guoping and Ouyang, Dongsheng and Zhu, Xiao and Wang, Yixue},
  title = {Population pharmacokinetics of caspofungin in critically ill Chinese children: a prospective observational study},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  doi = {10.1128/aac.01277-25}
}
Kostenlos starten →